Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @TickerReport | 7 |
| @intercooleronli | 7 |
| @SPNewsAnalysis | 6 |
| @Bizquick | 6 |
| @DrTranBioSci | 5 |
Recent Tweets for EXEL
 |
@allincapital 25 handle I'll circle back on $EXEL https://t.co/DJ0yynmWFG July 27th 2017, 10:07pm |
 |
@RatingsNetwork Exelixis's outperform rating reiterated at William Blair. https://t.co/ZGuP8BVOwS $EXEL #EXEL July 27th 2017, 4:07pm |
 |
@stockassassin74 @stefanomjr $tsro more likely to be next $exel July 27th 2017, 8:07am |
 |
@Afolleso @pick1998_2 $MBVX My opinion: bankrupt or the next $EXEL x 2. Of course, they could be bought out early. Distressed financials. July 27th 2017, 3:07am |
 |
@DrTranBioSci Exelixis gained +2.28% today: this aggressive grower is riding on the wings of the cabozantinib franchises. $EXEL https://t.co/NN4MTkXkLo July 26th 2017, 5:07pm |
 |
@finboxio Our Exelixis, $EXEL fundamental analysis highlights stock's 20% undervalued b4 earnings next Wednesday… https://t.co/M8LFZZi6gx July 26th 2017, 3:07pm |
 |
@Bizquick $EXEL INSTITUTIONS TAKING PROFITS...FYI July 26th 2017, 2:07pm |
|
@Bizquick $EXEL expecting a pullback July 26th 2017, 12:07pm |
|
@Bizquick $EXEL if it dips below 27.85 it will probably go lower...imo July 26th 2017, 12:07pm |
 |
@storminvestor Exelixis, Inc. $EXEL Lowered to “Hold” at Zacks Investment Research https://t.co/h3cEz2KsVG July 25th 2017, 8:07pm |
 |
@SPNewsAnalysis Exelixis, Inc. $EXEL Lowered to “Hold” at Zacks Investment Research https://t.co/fed79zbCH1 July 25th 2017, 8:07pm |
 |
@midetimes Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Exelixis $EXEL Share Price https://t.co/Grp4Y0obN7 July 25th 2017, 6:07pm |
 |
@TheMarketsDaily Exelixis $EXEL Receiving Somewhat Favorable Media Coverage, Study Finds https://t.co/2HW3XW63Fj July 25th 2017, 6:07pm |
 |
@dailypoliticaln Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Exelixis $EXEL Share Price https://t.co/4PNwGYPGqk July 25th 2017, 6:07pm |
 |
@SleekMoneycom Exelixis, Inc. Expected to Post FY2019 Earnings of $1.54 Per Share $EXEL https://t.co/x7HhOUDSSC July 25th 2017, 4:07pm |
|
@dailypoliticaln Exelixis, Inc. $EXEL Shares Sold by Insight Capital Research & Management Inc. https://t.co/tKCLDFegQC July 25th 2017, 2:07pm |
|
@TheMarketsDaily Insight Capital Research & Management Inc. Has $2.41 Million Position in Exelixis, Inc. $EXEL https://t.co/ruWoy6TZ6H July 25th 2017, 2:07pm |
|
@DrTranBioSci Exelixis is excelling w/+3.23% gains for the day. Cabozantinib is stellar & will deliver substantial profits. $EXEL https://t.co/NN4MTkXkLo July 24th 2017, 5:07pm |
 |
@IRAMarketReport Short Interest in Exelixis, Inc. $EXEL Drops By 8.1% https://t.co/ZPb2HogcP0 July 24th 2017, 4:07pm |
 |
@chaffeybreeze Short Interest in Exelixis, Inc. $EXEL Drops By 8.1% https://t.co/vA9oqjaqbw July 24th 2017, 4:07pm |
 |
@ITRADEVOL $EXEL Exelixis Best/Worst Trading Hour Summary (20 Day) https://t.co/IwGSsIcbeH July 24th 2017, 1:07pm |
 |
@JXMfinance $EXEL is working on a 10% July. https://t.co/BSniIVKAgS July 24th 2017, 1:07pm |
 |
@CashRocket Beautiful little trade for 40% gains in $EXEL, props to @OptionsHawk for flagging sale of 3K Aug 25P on 7/19 as a t… https://t.co/g2ovXLATAw July 24th 2017, 1:07pm |
 |
@1MinuteStock Unicorn Bay rating for $EXEL is 2.83 out of 5. https://t.co/Lw8PCl4AEv July 24th 2017, 12:07pm |
 |
@artworktrades RT @TMLTrader: $EXEL back at multi-year high after a brief pullback to its 10-day MA. https://t.co/NvqjYp0QZD July 24th 2017, 12:07pm |
 |
@TMLTrader $EXEL back at multi-year high after a brief pullback to its 10-day MA. https://t.co/NvqjYp0QZD July 24th 2017, 12:07pm |
|
@CashRocket $EXEL new YTD highs ahead of 8/2 EPS. Cabo estimates are still too low. CELESTIAL Phase 3 data also expected 2H17. July 24th 2017, 11:07am |
 |
@vivazapata173 $EXEL Take a look at AVEO. Tivozanib Recommended for Approval in EU for Renal Cell Carcinoma. Approval date end of Aug Accumulating now. July 24th 2017, 11:07am |
 |
@tinmanken $EXEL to test 28.00 July 24th 2017, 11:07am |
 |
@intercooleronli FY2019 Earnings Estimate for Exelixis, Inc. $EXEL Issued By Leerink Swann https://t.co/sNzmu04h4z July 24th 2017, 11:07am |
|
@SleekMoneycom Meeder Asset Management Inc. Purchases 2,091 Shares of Exelixis, Inc. $EXEL https://t.co/MiX6J6gaOe July 24th 2017, 10:07am |
 |
@rosderek @TBowers77 And updated Cobi cost / rev split w Genentech should add solid value to cobi franchise for $exel, value was murky in the past July 23rd 2017, 6:07pm |
|
@SleekMoneycom Exelixis, Inc. Forecasted to Earn FY2018 Earnings of $0.66 Per Share $EXEL https://t.co/57ggJTTa2s July 23rd 2017, 8:07am |
 |
@clarklsn2001 @ohmsonite Thoughts on the what could be the next baby $exel? July 22nd 2017, 6:07pm |
 |
@YuZhu4 RT @RNAiAnalyst: $EXEL an example of biotech w/ strong scientific base where it was mainly matter of time 'til they hit a home-run. https:/… July 22nd 2017, 4:07pm |
 |
@RNAiAnalyst $EXEL an example of biotech w/ strong scientific base where it was mainly matter of time 'til they hit a home-run. https://t.co/WJRp4H6GTZ July 22nd 2017, 4:07pm |
 |
@portefeuillefun RT @ohmsonite: Finally sold the last chunk of $EXEL. Really happy with my patience with this company - 530% long term gain. Wish I have mor… July 22nd 2017, 4:07pm |
 |
@ohmsonite Finally sold the last chunk of $EXEL. Really happy with my patience with this company - 530% long term gain. Wish I have more of those, ha! July 22nd 2017, 3:07pm |
|
@IRAMarketReport Exelixis, Inc. to Post FY2018 Earnings of $0.66 Per Share, Leerink Swann Forecasts $EXEL https://t.co/SmmKygX2aq July 22nd 2017, 12:07pm |
 |
@TickerReport William Blair Comments on Exelixis, Inc.’s FY2018 Earnings $EXEL https://t.co/iXVQIt4ldH July 22nd 2017, 12:07pm |
 |
@biotech_sector #Exelixis Bristol-Myers Squibb (BMY) & Exelis Commence Phase 3 Trial of Opdivo in Combinati... Read more: https://t.co/M6yJ9oN0cb $EXEL July 22nd 2017, 11:07am |
 |
@WeekHerald Exelixis, Inc. to Post FY2018 Earnings of $0.66 Per Share, Leerink Swann Forecasts $EXEL https://t.co/KRZl7xDLNy July 22nd 2017, 11:07am |
|
@WeekHerald William Blair Comments on Exelixis, Inc.’s FY2018 Earnings $EXEL https://t.co/sQo7yeaATW July 22nd 2017, 11:07am |
 |
@astruzynski $EXEL weekly. Inside week week https://t.co/3QinALmokl July 22nd 2017, 6:07am |
 |
@AlertTrade #SwingTradeAlert $EXEL technical alerts: Stochastic Reached Overbought, Narrow Range… https://t.co/Iln3zOP0Zn via ? https://t.co/3vJdaf0nJa July 22nd 2017, 5:07am |
 |
@SwingTradeBot $EXEL technical alerts: Stochastic Reached Overbought, Narrow Range Bar, NR7-2, and NR7 https://t.co/R8mMMMOolt July 22nd 2017, 5:07am |
|
@Bizquick @nobullshytrader That sucks bro short $EXEL THEN LOL July 21st 2017, 8:07pm |
 |
@dailymailtimes Exelixis’ $EXEL Hold Rating Reaffirmed at Cann https://t.co/ejbmNm3gqK July 21st 2017, 7:07pm |
|
@storminvestor Exelixis’ $EXEL Hold Rating Reaffirmed at Cann https://t.co/Izp7nDqu7N July 21st 2017, 7:07pm |
|
@SPNewsAnalysis Exelixis’ $EXEL Hold Rating Reaffirmed at Cann https://t.co/KI8XCpVI52 July 21st 2017, 7:07pm |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.